Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Temozolomide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 6,643Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Allarity's Ph2 Stenoparib Lung Cancer Trial Fully Funded By VA
    Allarity's Ph2 Stenoparib Lung Cancer Trial Fully Funded By VA

    06 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/06/3038114/0/en/Allarity-Therapeutics-Announces-Phase-2-Trial-of-Stenoparib-in-Combination-with-Temozolomide-for-Recurrent-Small-Cell-Lung-Cancer-Fully-Funded-by-the-US-Veterans-Administration.html

    GLOBENEWSWIRE
    06 Mar 2025
    Share Share
    Nanopharmaceutics, Northwestern Initiate Oral Triapine+TMZ Recurrent GBM Study
    Nanopharmaceutics, Northwestern Initiate Oral Triapine+TMZ Recurrent GBM Study

    14 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nanopharmaceutics-and-northwestern-university-announce-initiation-of-phase-i-adaptive-dose-escalation-clinical-study-with-dose-expansion-of-oral-triapine-in-combination-with-temozolomide-tmz-for-patients-with-recurrent-glioblas-302145367.html

    PR NEWSWIRE
    14 May 2024
    Share Share
    ORPHELIA Pharma Selects Tanner Pharma Group to Initiate Named Patient Program
    ORPHELIA Pharma Selects Tanner Pharma Group to Initiate Named Patient Program

    18 Apr 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230418005094/en

    BUSINESSWIRE
    18 Apr 2023
    Share Share
    NPPA revises ceiling prices of 128 formulations
    NPPA revises ceiling prices of 128 formulations

    17 Jan 2023

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-revises-ceiling-prices-of-128-formulations/articleshow/97033906.cms

    ECONOMIC TIMES
    17 Jan 2023
    Share Share
    Merck Enters Collaboration with Nerviano to Develop PARP1 Selective Inhibitor
    Merck Enters Collaboration with Nerviano to Develop PARP1 Selective Inhibitor

    22 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220921005109/en

    BUSINESSWIRE
    22 Sep 2022
    Share Share
    OncXerna's Upcoming ASCO Poster Featuring Data of PII Glioblastoma Trial
    OncXerna's Upcoming ASCO Poster Featuring Data of PII Glioblastoma Trial

    03 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/03/2455957/0/en/OncXerna-Therapeutics-Announces-Upcoming-ASCO-Poster-Featuring-Data-Showing-the-Phase-2-Glioblastoma-Trial-of-Bavituximab-with-Chemoradiation-and-Adjuvant-Temozolomide-Met-its-Prim.html

    GLOBENEWSWIRE
    03 Jun 2022
    Share Share